Recognizing the sight of blood in urine, the most common first sign of bladder cancer, is often the impetus that leads people to a diagnosis. But for those with colorblindness, who usually have ...

(Reuters) -Pfizer and Japanese firm Astellas' drug Padcev, combined with Merck's Keytruda, lowered the risk of tumor recurrence, progression or death in patients suffering from a type of bladder ...

A large U.S. health records study suggests that difficulty seeing blood in urine may put color-blind patients at higher risk.

Out of sight, out of mind. A new study suggests a common eye condition could be quietly masking one of the only early warning ...

People with color blindness may be less able to spot an early sign of bladder cancer, making them likelier to be diagnosed ...

First and only combination regimen to improve survival when used before and after surgical cystectomy in cisplatin-ineligible patients with muscle-invasive bladder cancer Unprecedented survival ...

Enfortumab vedotin and pembrolizumab with surgery significantly improve outcomes in cisplatin-ineligible MIBC patients, reducing disease progression or death risk by 60%. The EV-303/KEYNOTE-905 trial ...